Emma Danks is head of our UK corporate/M&A group, co-head of our global corporate/M&A group and a member of the UK Executive Board. She is recognised as one of the UK’s leading private equity lawyers and is described by clients as bright, commercial, and solutions focused. Emma is well known for her work with private equity sponsors and their portfolio companies, having acted on a wide range of leveraged buyouts and related transactions. She also frequently advises private equity backed management teams on buyout transactions and equity plans.

Emma also has specific life sciences and healthcare experience, having acted for several generic pharmaceutical companies on both buy-side and sell-side M&A transactions, as well as PE sponsors investing in this sector.

Emma was listed in The Lawyer's Hot 100 for 2018, and in the Legal Business feature on the City's female deal stars. Her team’s buyout expertise was recently recognised when they were named Private Equity Team of the Year at the British Legal Awards.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Capital investissement

Taylor Wessing advises in Inflexion's £400 million sale of Chambers to Abry Partners

14 novembre 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Emma Danks comments in The Times on global M&A activity this year and future prospects for deal-seeking companies

5 octobre 2023
Quick read

par Emma Danks

Cliquer ici pour en savoir plus
Capital investissement

Sedex on securing investment from LDC

14 août 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Bridgepoint on its sale of one.network

7 août 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus